Simplify Logo

Full-Time

Research Informatics Technical Business Partner

Confirmed live in the last 24 hours

Relay Therapeutics

Relay Therapeutics

201-500 employees

Biotech company focused on drug discovery

Healthcare
Biotechnology

Mid

Cambridge, MA, USA

Category
Bioinformatics
Biology Lab & Research
Biology & Biotech
Required Skills
Agile
Python
R
Git
Requirements
  • Experience in working with implementation, integration, and configuration of digital scientific solutions required.
  • Deep knowledge of Signals ELN and Signal Parallels product, including automated workflows, integrations with these products, and creation of templates
  • Experience with compound inventory systems, such as Titian Mosaic, which facilitate inventory and automated dispensing workflows
  • Technical understanding of databases (implementation of data models, query construction, integration tasks, and ETL operations)
  • Experience with at least one programming/scripting languages and programmatic interfaces (APIs)e.g., Python, R, or similar, to be able to transform / analyze various scientific data
  • You must have an Agile mindset and have experience configuring and using JIRA, Confluence, GitLab and other SLDC systems
  • BS, MS, or PhD in Chemistry, Informatics, or Computer Science
  • 3+ years' experience working within a Biotech or Pharma informatics organization, or in a technical scientific role
  • In-depth knowledge of life sciences R&D processes with fluency speaking about science and scientific data models, process engineering, and analysis results.
  • Solid grounding in chemistry laboratory automation.
Responsibilities
  • Collaborate with the Chemical Technologies, Chemistry and Compound Management teams to foster a culture of scientific excellence, data curation, best practices, and project impact.
  • Identify opportunities to improve chemical workflows though software tools and laboratory practices to drive build-out and adoption of your ideas.

Relay Therapeutics focuses on drug discovery by emphasizing the movement of proteins in its research. The company uses its Dynamo™ platform, which integrates experimental and computational methods, to identify and develop new drugs, particularly for complex diseases that are hard to treat with traditional approaches. This platform enables Relay to target proteins that have previously been difficult to address, expanding treatment options, especially in precision oncology and genetic diseases. Unlike its competitors, Relay Therapeutics collaborates with major biotech firms, such as Genentech, to validate its technology and generate revenue through licensing and partnerships. The main goal of Relay Therapeutics is to create impactful medicines for patients, and it is actively conducting clinical trials to ensure the safety and effectiveness of its drug candidates.

Company Stage

IPO

Total Funding

$1.2B

Headquarters

Cambridge, Massachusetts

Founded

2016

Growth & Insights
Headcount

6 month growth

-2%

1 year growth

-10%

2 year growth

-3%
Simplify Jobs

Simplify's Take

What believers are saying

  • Relay's focus on precision oncology and genetic diseases positions it at the forefront of personalized medicine, offering significant growth potential.
  • Recent investments and financing, including a $30 million private placement and $400 million Series C financing, indicate strong financial backing and investor confidence.
  • Initial clinical data for RLY-2608 and other promising drug candidates highlight the company's potential for successful therapeutic developments.

What critics are saying

  • The highly competitive biotech sector requires continuous innovation to maintain a leading position.
  • Dependence on strategic partnerships and licensing agreements could pose risks if collaborations do not yield expected results.

What makes Relay Therapeutics unique

  • Relay Therapeutics places protein motion at the core of its drug discovery process, a unique approach that sets it apart from traditional methods.
  • The Dynamo™ platform combines experimental and computational techniques to target previously undruggable proteins, expanding treatment possibilities.
  • Strategic collaborations, such as the one with Genentech, validate the potential of Relay's innovative technology and approach.

Benefits

Medical, dental, vision

Life, disability, & FSA

401k

Commuter benefits

Parental leave

Home office stipend

Tuition reimbursement

PTO